UY31539A1 - Agentes antelminticos y su uso - Google Patents
Agentes antelminticos y su usoInfo
- Publication number
- UY31539A1 UY31539A1 UY31539A UY31539A UY31539A1 UY 31539 A1 UY31539 A1 UY 31539A1 UY 31539 A UY31539 A UY 31539A UY 31539 A UY31539 A UY 31539A UY 31539 A1 UY31539 A1 UY 31539A1
- Authority
- UY
- Uruguay
- Prior art keywords
- salts
- compounds
- agents
- antelmintic
- treatments
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
- C07D295/104—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/108—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Esta invencion está dirigida a los compuestos y a las sales que son generalmente utiles como agentes antelmínticos, o como intermediarios en los procesos para hacer agentes antelmínticos. Esta invencion también está dirigida a los procesos para hacer los compuestos y las sales, a las composiciones farmacéuticas y a los juegos que comprende los compuestos y las sales, a los usos de los compuestos y las sales para hacer los medicamentos, y a los tratamientos comprendiendo la administracion de los compuestos y las sales a los animales en necesidad de los tratamientos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1424207P | 2007-12-17 | 2007-12-17 | |
EP08101961 | 2008-02-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
UY31539A1 true UY31539A1 (es) | 2009-08-03 |
Family
ID=39563449
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY31539A UY31539A1 (es) | 2007-12-17 | 2008-12-17 | Agentes antelminticos y su uso |
Country Status (14)
Country | Link |
---|---|
US (1) | US8569495B2 (es) |
EP (1) | EP2234973B1 (es) |
CN (1) | CN101896459B (es) |
AR (1) | AR069772A1 (es) |
AU (1) | AU2008337482B2 (es) |
BR (1) | BRPI0822033B1 (es) |
CA (1) | CA2709407A1 (es) |
ES (1) | ES2501544T3 (es) |
NZ (1) | NZ586087A (es) |
PE (1) | PE20091453A1 (es) |
TW (1) | TW200938203A (es) |
UY (1) | UY31539A1 (es) |
WO (1) | WO2009077527A1 (es) |
ZA (1) | ZA201004261B (es) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010114907A1 (en) | 2009-03-31 | 2010-10-07 | Vanderbilt University | Sulfonyl-azetidin-3-yl-methylamine amide analogs as glyt1 inhibitors, methods for making same, and use of same in treating psychiatric disorders |
CA2813189C (en) | 2010-09-29 | 2020-04-28 | Sk Biopharmaceuticals Co., Ltd. | Novel methylcyclohexane derivatives and uses thereof |
EP2468096A1 (en) | 2010-12-21 | 2012-06-27 | Intervet International BV | Anthelmintic combinations |
WO2014081697A2 (en) * | 2012-11-20 | 2014-05-30 | Merial Limited | Anthelmintic compounds and compositions and method of using thereof |
FR3000065A1 (fr) * | 2012-12-21 | 2014-06-27 | Univ Lille Ii Droit & Sante | Composes bicycliques ayant une activite potentialisatrice de l'activite d'un antibiotique actif contre les mycobacteries-composition et produit pharmaceutiques comprenant de tels composes |
EP3145925B1 (en) | 2014-05-19 | 2020-11-04 | Boehringer Ingelheim Animal Health USA Inc. | Anthelmintic compounds |
WO2016005577A1 (en) * | 2014-07-11 | 2016-01-14 | Intervet International B.V. | Use of anthelmintic agents against dirofilaria immitis |
EP3177291A1 (en) * | 2014-07-11 | 2017-06-14 | Intervet International B.V. | Use of anthelmintic agents against dirofilaria immitis |
US10597364B2 (en) | 2015-01-20 | 2020-03-24 | Boehringer Ingelheim Animal Health USA Inc. | Anthelmintic compounds, compositions and method of using thereof |
CA3026982A1 (en) | 2016-06-08 | 2017-12-14 | Glaxosmithkline Intellectual Property Development Limited | Chemical compounds as atf4 pathway inhibitors |
AU2018240172C1 (en) | 2017-03-20 | 2019-10-24 | Novo Nordisk Health Care Ag | Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators |
ES2919779T3 (es) | 2017-06-20 | 2022-07-28 | Imbria Pharmaceuticals Inc | Derivado de 1-[(2,3,4-trimetoxifenil)metil]-piperazina, composiciones del mismo y métodos para aumentar la eficiencia del metabolismo cardíaco |
CN107987012A (zh) * | 2018-01-29 | 2018-05-04 | 田元强 | 一种4-苄基哌啶类酰胺化合物及其在防治植物线虫病害中的应用 |
CN113226356A (zh) | 2018-09-19 | 2021-08-06 | 福马治疗股份有限公司 | 活化丙酮酸激酶r |
US10675274B2 (en) | 2018-09-19 | 2020-06-09 | Forma Therapeutics, Inc. | Activating pyruvate kinase R |
US11780811B2 (en) | 2020-06-30 | 2023-10-10 | Imbria Pharmaceuticals, Inc. | Methods of synthesizing 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate |
US11530184B2 (en) | 2020-06-30 | 2022-12-20 | Imbria Pharmaceuticals, Inc. | Crystal forms of 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate |
US11883396B2 (en) | 2021-05-03 | 2024-01-30 | Imbria Pharmaceuticals, Inc. | Methods of treating kidney conditions using modified forms of trimetazidine |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB819681A (en) * | 1957-01-24 | 1959-09-09 | Wellcome Found | Improvements in and relating to quaternary ammonium compounds and the preparation thereof |
GB1032251A (en) * | 1961-06-22 | 1966-06-08 | Wellcome Found | Piperazine compounds and their preparation |
CH542828A (de) * | 1970-09-02 | 1973-10-15 | Agripat Sa | Verfahren zur Herstellung neuer Thioharnstoffe |
US4247710A (en) * | 1978-02-08 | 1981-01-27 | Hoffmann-La Roche Inc. | Intermediate in the production of adrenergic blocking agents |
DE19529604A1 (de) * | 1995-08-11 | 1997-02-13 | Bayer Ag | Endoparasitizide Mittel auf Basis von Didepsipeptiden, neue Didepsipeptide und ein Verfahren zu ihrer Herstellung |
FR2740134B1 (fr) * | 1995-10-18 | 1998-01-09 | Pf Medicament | Derives d'amines cycliques d'aryl-piperazines, leur preparation et les compositions pharmaceutiques les contenant |
WO2000035877A1 (en) * | 1998-12-18 | 2000-06-22 | Du Pont Pharmaceuticals Company | Heterocyclic piperidines as modulators of chemokine receptor activity |
-
2008
- 2008-12-10 TW TW097148018A patent/TW200938203A/zh unknown
- 2008-12-16 ES ES08863299.7T patent/ES2501544T3/es active Active
- 2008-12-16 CN CN2008801201693A patent/CN101896459B/zh not_active Expired - Fee Related
- 2008-12-16 PE PE2008002081A patent/PE20091453A1/es not_active Application Discontinuation
- 2008-12-16 NZ NZ586087A patent/NZ586087A/en not_active IP Right Cessation
- 2008-12-16 US US12/808,897 patent/US8569495B2/en active Active
- 2008-12-16 BR BRPI0822033A patent/BRPI0822033B1/pt not_active IP Right Cessation
- 2008-12-16 CA CA2709407A patent/CA2709407A1/en not_active Abandoned
- 2008-12-16 EP EP08863299.7A patent/EP2234973B1/en active Active
- 2008-12-16 AU AU2008337482A patent/AU2008337482B2/en active Active
- 2008-12-16 WO PCT/EP2008/067621 patent/WO2009077527A1/en active Application Filing
- 2008-12-17 AR ARP080105480A patent/AR069772A1/es not_active Application Discontinuation
- 2008-12-17 UY UY31539A patent/UY31539A1/es unknown
-
2010
- 2010-06-15 ZA ZA2010/04261A patent/ZA201004261B/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN101896459B (zh) | 2013-07-24 |
ES2501544T3 (es) | 2014-10-02 |
ZA201004261B (en) | 2011-02-23 |
NZ586087A (en) | 2011-08-26 |
AU2008337482B2 (en) | 2013-09-12 |
EP2234973B1 (en) | 2014-07-02 |
CA2709407A1 (en) | 2009-06-25 |
AU2008337482A1 (en) | 2009-06-25 |
BRPI0822033A2 (pt) | 2015-07-21 |
CN101896459A (zh) | 2010-11-24 |
WO2009077527A1 (en) | 2009-06-25 |
US20110021506A1 (en) | 2011-01-27 |
AR069772A1 (es) | 2010-02-17 |
PE20091453A1 (es) | 2009-10-03 |
EP2234973A1 (en) | 2010-10-06 |
TW200938203A (en) | 2009-09-16 |
US8569495B2 (en) | 2013-10-29 |
BRPI0822033B1 (pt) | 2018-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY31539A1 (es) | Agentes antelminticos y su uso | |
CO2020007218A2 (es) | Nuevas piridopirimidinonas sustituidas con bencilamino y derivados como inhibidores de sos1 | |
PA8622401A1 (es) | Derivados de acido 7-fenilamino-4-quinolona-3-carboxilico,procesos para su preparacion y su uso como medicamentos | |
UY28757A1 (es) | Compuestos de pirazolina substituidos, su preparación y su uso como medicamentos | |
PA8660301A1 (es) | Pirazolo piridinas sustituidas, composiciones que las contienen, procedimiento de fabricacion y utilizacion | |
CR10304A (es) | Compuestos de tetrahidropiridotienopirimidina y procedimientos de uso de los mismos | |
DOP2010000134A (es) | Algunos derivados de 2-pirazinona como inhibidores de elastasa de los neutrofilos | |
HN2011001593A (es) | Piridiloxi-indoles del vegf-r2 y uso de los mismos para el tratmiento de enfermedades | |
UY32502A (es) | Agentes antihelmínticos y su utilización | |
GT200500378A (es) | Macrolidos | |
GT200600316A (es) | Sales de 4-metilo-n-(3-(4-metilo-imidazol-1-ilo)-5-trifluorometilo-fenilo)-3-(4-piridina-3-ilo-pirimidina-2-iloamino)- benzamida. | |
GT200600025A (es) | Pirazolopiridinas y sales de las mismas, una composicion farmaceutica que comprende dichos compuestos, un metodo para prepararlos y su uso | |
UY30282A1 (es) | Compuestos quimicos | |
PA8720801A1 (es) | Nuevas combinaciones terapeuticas para el tratamiento de la depresion | |
HN2010001920A (es) | Dihidropirazolonas sustituidas como inhibidores de hif- propil-4-hidroxilasa | |
CO6710926A2 (es) | Compuestos de n-heteroarilo | |
ECSP12011617A (es) | Carboxamidas pesticidas | |
UY30585A1 (es) | Derivados de isoserina como inhibidores del factor ixa de la coagulacion | |
UY31637A1 (es) | Farmacoforos duales-antagonistas muscarinicos de pde4 | |
PA8720601A1 (es) | Nuevas combinaciones terapeuticas para el tratamiento o la prevenciòn de trastornos psicoticos | |
PA8661101A1 (es) | Compuestos antihelminticos | |
PA8661601A1 (es) | Pirroles sustituidos, composiciones que los contienen, proceso de fabricacion y utilizacion | |
UY31805A (es) | Agonistas m1, composiciones farmacéuticas de los mismos, procesos para su preparacion y sus usos para el tratamiento del dolor | |
AR051429A1 (es) | Composicion farmaceutica ozonizada y metodos para obtenerla | |
UY31252A1 (es) | Derivados de macrolidos utiles en el tratamiento de la malaria |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
DESI | Application deemed to be withdrawn |
Effective date: 20121123 |